Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Graded Insulin Suppression Test P&F

Phase 1

Recruiting

Conditions: Insulin Resistance
Hyperinsulinemia
Obesity
Healthy

Interventions: Drug: Insulin regular, 2.0-3.2 mU/m2/min (euinsulinemia)
Drug: Insulin regular, 32 mU/m2/min (hyperinsulinemia)
Drug: Octreotide Acetate, 6-45 ng/kg/min
Drug: Dextrose 20 % in Water
Drug: Glucagon, 0-0.5 ng/kg/min

First Posted Date: 2024-09-19

Last Posted Date: 2025-01-16

Lead Sponsor: Columbia University

Target Recruit Count: 15

Registration Number: NCT06592261

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Body Electric: a Pragmatic Trial Evaluating the Viability of Movement Breaks

Not Applicable

Completed

Conditions: Sedentary Behavior

First Posted Date: 2024-09-12

Last Posted Date: 2024-09-19

Lead Sponsor: Columbia University

Target Recruit Count: 20217

Registration Number: NCT06592209

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Ablation Guided Via Precision Imaging Using Electromechanical Wave Imaging

Not Applicable

Conditions: Arrhythmias, Cardiac

First Posted Date: 2024-08-29

Last Posted Date: 2025-04-24

Lead Sponsor: Columbia University

Target Recruit Count: 322

Registration Number: NCT06577714

Locations: 🇺🇸
Columbia University, New York, New York, United States

A Study of Gemcitabine/Cisplatin Plus Cemiplimab (REGN2810, Anti-PD-1) With or Without Fianlimab (REGN3767, Anti-LAG-3) in Patients With Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

Phase 2

Not yet recruiting

Conditions: Muscle-Invasive Bladder Carcinoma
Bladder Cancer

Interventions: Drug: Gemcitabine
Drug: Cisplatin
Drug: Cemiplimab
Drug: Fianlimab

First Posted Date: 2024-08-26

Last Posted Date: 2025-07-01

Lead Sponsor: Columbia University

Target Recruit Count: 36

Registration Number: NCT06571708

Locations: 🇺🇸
Columbia University Irving Medical Center/ New York Presbyterian Hospital, New York, New York, United States

The Sleep2BWell Trial

Not Applicable

Active, not recruiting

Conditions: Diet, Healthy
Weight Loss
Physical Activity
Blood Pressure
Sleep Health

First Posted Date: 2024-08-21

Last Posted Date: 2025-04-13

Lead Sponsor: Columbia University

Target Recruit Count: 210

Registration Number: NCT06565104

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Columbia University Irving Medical Center, Mailman School of Public Health, New York, New York, United States

Human Models of Selective Insulin Resistance: Pancreatic Clamp

Phase 1

Not yet recruiting

Conditions: Insulin Resistance
Hyperinsulinemia
Metabolic Dysfunction Associated Steatotic Liver Disease
Non-Alcoholic Fatty Liver Disease
Prediabetic State
Obesity

Interventions: Drug: Insulin human
Drug: Octreotide Acetate
Drug: Glucagon
Drug: Growth Hormone, Human
Drug: 20% D-glucose (aq)
Diagnostic Test: [6,6-2H2] D-glucose
Diagnostic Test: [1-13C1] sodium acetate
Dietary Supplement: Nestle BOOST Plus
Dietary Supplement: KIND Bar
Device: Harvard Apparatus PHD ULTRA CP syringe pump
Device: Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer

First Posted Date: 2024-08-16

Last Posted Date: 2025-01-08

Lead Sponsor: Columbia University

Target Recruit Count: 36

Registration Number: NCT06558422

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Effects of tDCS and VNS on Postoperative Analgesia

Not Applicable

Not yet recruiting

Conditions: Acute Postoperative Pain

First Posted Date: 2024-08-14

Last Posted Date: 2024-08-14

Lead Sponsor: Columbia University

Target Recruit Count: 200

Registration Number: NCT06554067

Medically Tailored Meals for Cardiovascular Health Equity

Not Applicable

Recruiting

Conditions: Diet, Healthy
HbA1c
Blood Pressure

First Posted Date: 2024-08-13

Last Posted Date: 2024-10-16

Lead Sponsor: Columbia University

Target Recruit Count: 200

Registration Number: NCT06550297

Locations: 🇺🇸
Columbia University Mailman School of Public Health, New York, New York, United States

Prediction of Anxiety and Memory State

Recruiting

Conditions: Anxiety
Epilepsy
Memory

First Posted Date: 2024-08-13

Last Posted Date: 2025-01-17

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT06551090

Locations: 🇺🇸
Columbia University, New York, New York, United States

Engaging Patients in Adherence Interventions Using Behavioral Science

Not Applicable

Active, not recruiting

Conditions: Uncontrolled Hypertension

First Posted Date: 2024-08-09

Last Posted Date: 2025-04-01

Lead Sponsor: Columbia University

Target Recruit Count: 584

Registration Number: NCT06543394

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy